"AI isn't coming for clinical development, it's already sitting at the table."

The Kitsa and Hemex teams at Tech Park Basel
At Tech Park Basel, Kitsa and Hemex came together for a Lunch & Learn on AI-driven protocol development, and what unfolded was a sharp, honest and high energy conversation about how clinical research is about to be re-engineered from its very foundation.
Our CTO Rohit Banga walked the room through how we're building an intelligence layer that doesn't just support protocol design… it transforms it. Turning static PDFs into dynamic, adaptive frameworks, compressing months of design cycles into days, and giving researchers something they've rarely had before; clarity and speed at the same time.
This isn't just automation. This is about making clinical protocols living systems that learn, iterate and adapt with real-time intelligence.
Massive shoutout to Mohamed Hussien, PharmD, PhD for driving this collaboration with the Hemex team and to everyone who showed up with thoughtful questions and curiosity. These are the conversations that shape the future.
of Phase II/III protocols require amendments
Cost per amendment plus 3-6 months delay
of trial delays stem from protocol design issues
Historical trials powering AI insights
Building an AI layer that doesn't just support protocol design; it transforms it
Compressing months of design cycles into days while providing unprecedented clarity
Making clinical protocols living systems that learn, iterate and adapt with real-time intelligence
Turning static PDFs into dynamic, adaptive frameworks for modern clinical development
Upload draft or start from scratch
Context-aware agent suggests improvements
Review past trials and competitor protocols
Feasibility by site and population
Teams co-edit with version tracking
Export compliant, review-ready protocol
From reactive editing → to proactive design intelligence.




Keep exploring
Roundtable on AI in clinical operations with Swiss biotech leaders.
Explore how AI simulation, agentic document generation, and connected clinical workflows are reshaping protocol design and trial execution.
Real-time signals that keep trials on schedule and on budget.
Point-solution AI is giving way to AI-native clinical operations. Learn how sponsors, CROs, and sites are rebuilding trial workflows from the ground up.